Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Universidade Federal da Sao Paulo

     
Sao Paulo ,
Brazil

 

Principal Investigator:
 Nora M. Forones MD
Contact:
 Elizabeth PM de Almeida +55 11 5576 4050 elizabeth.almeida@unifesp.br
Activation Status of this Site:
 Closed
Notes about this Site:
Universidade Federal da Sao Paulo Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.